ArticleScientific reports2017

Ex vivo treatment of patient biopsies as a novel method to assess colorectal tumour response to the MEK1/2 inhibitor, Selumetinib.

Sonia M Novo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.